更新时间：2025-07-12 直链：www.ramancare.com

WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity，foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.

更新时间：2025-07-11 直链：westvacpharma.com

LABOAOadalahperusahaanteknologitinggiyangmengintegrasikanR&D,produksi,penjualan,impordanekspor,danmerupakanpenyediasolusiperalatanlaboratoriumterkemukadiCina.BisnisutamaLABOAOmelibatkaninstrumen/bahanhabispakailaboratorium,instrumenilmuhayati,instrumenanalisiskimia,instrumenoptik,medisperalatan,instrumeninspeksiobat,instrumenpertanian,instrumeninspeksimakanandaninstrumenterkaitindustrilainnya.

更新时间：2025-07-10 直链：id.laboao.com

公司专业从事高性能工业陶瓷的生产，专注于压铸、压制和精密磨削技术，生产包括组装件在内的各类高性能陶瓷，也从事陶瓷制品、复合树脂制品、化纤机械配件等的生产及电子产品组装等。产品应用范围广泛，涵盖纺织和电线行业、汽车、焊接、激光等领域。公司拥有模具制造中心，可根据客户要求生产任何形状的产品，不仅为纺织企业提供零配件，也为亚洲地区生产纺织机械的厂家定制产品。公司按照ISO9001管理体系认证要求，在生产过程中有专门的质量控制部门对产品质量进行监督，从原材料到成品，每个环节都严格把控，确保产品符合高质量标准。

更新时间：2025-07-02 直链：www.ceramany.cn

苏州光格科技股份有限公司（股票代码：688450.SH）是专注于新一代光纤传感网络与资产数字化运维管理系统研发、生产与销售的高新技术企业，为资产密集型企业的线性资产提供状态监测、预测性维护和全生命周期管理的解决方案，实现资产的数字化、精益化、智能化管理，提升运行管理水平。

更新时间：2025-06-30 直链：www.agioe.com

LABOAOisahigh-techenterpriseintegratingR&D,production,sales,importandexport,andisaleadinglaboratoryequipmentsolutionproviderinChina.LABOAO'smainbusinessinvolveslaboratoryinstruments/consumables,lifescienceinstruments,chemicalanalysisinstruments,opticalinstruments,medicalequipment,druginspectioninstruments,agriculturalinstruments,foodinspectioninstrumentsandotherindustry-relatedinstruments.

更新时间：2025-06-28 直链：laboaovideo.com

专为ULTRAARTS奥特曼迷打造的特设信息站点

更新时间：2025-06-25 直链：www.tamashiinations.cn